OTCMKTS:TLPPF Telix Pharmaceuticals (TLPPF) Stock Price, News & Analysis $9.43 0.00 (0.00%) As of 11/12/2026 Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartFinancialsNews and TrendsSEC Filings About Telix Pharmaceuticals Stock (OTCMKTS:TLPPF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Telix Pharmaceuticals alerts:Sign Up Key Stats Today's Range$9.43▼$9.4350-Day Range$8.75▼$12.5552-Week Range$5.91▼$13.00Volume50 shsAverage Volume3,850 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice Target$21.00Consensus RatingBuy Company Overview Telix Pharmaceuticals is an Australian biopharmaceutical company focused on developing and commercializing radiopharmaceuticals for cancer diagnosis and treatment. Its work combines radioactive isotopes with molecules designed to target specific tumor cells. The company’s products and development programs include imaging agents for detecting and assessing cancer, as well as therapeutic candidates intended to deliver radiation to tumors. Its Illuccix product is used in prostate cancer imaging. Telix conducts commercial and development activities in markets including Australia, North America and Europe. Its research programs span several cancers, including prostate, kidney and brain cancers.AI Generated. May Contain Errors. Read More Receive TLPPF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Telix Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TLPPF Stock News HeadlinesAustralia's Telix Pharma agrees to buy Germany's ITM Isotope for about $1.65 billionSeptember 20, 2026 | reuters.comAnalysts Offer Insights on Healthcare Companies: Telix Pharmaceuticals (OtherTLPPF) and Takeda Pharmaceutical Co (OtherTKPHF)August 24, 2026 | theglobeandmail.comA little-known law has been quietly applied to your savings for years.Fox News reported that under current law, legal title to most stocks and bonds sits with a central institution, Cede and Company, not the individual investor. If a brokerage collapses and customer securities were pledged as collateral, secured creditors can legally come before account holders. Physical gold held in a self-directed IRA is registered directly to you, with no clearinghouse or central institution holding its title.November 13 at 1:00 AM | Monetary Gold (Ad)Analysts Are Bullish on These Healthcare Stocks: Telix Pharmaceuticals (TLPPF), Impedimed Limited (IPDQF)July 29, 2026 | theglobeandmail.comJ.P. Morgan Sticks to Its Buy Rating for Telix Pharmaceuticals (TLPPF)July 25, 2026 | theglobeandmail.comAnalysts Conflicted on These Healthcare Names: Pyxis Oncology (PYXS) and Telix Pharmaceuticals (OtherTLPPF)July 21, 2026 | theglobeandmail.comBell Potter Sticks to Its Buy Rating for Telix Pharmaceuticals (TLPPF)July 21, 2026 | theglobeandmail.comAnalysts Offer Insights on Healthcare Companies: Summit Therapeutics (SMMT) and Telix Pharmaceuticals (OtherTLPPF)May 27, 2026 | theglobeandmail.comSee More Headlines TLPPF Stock Analysis - Frequently Asked Questions How have TLPPF shares performed this year? Telix Pharmaceuticals' stock was trading at $7.7361 on January 1st, 2026. Since then, TLPPF shares have increased by 21.9% and is now trading at $9.4325. How do I buy shares of Telix Pharmaceuticals? Shares of TLPPF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolOTCMKTS:TLPPF CIK2007191 Webtelixpharma.com Phone61-3-3093-3897FaxN/AEmployees234Year FoundedN/APrice Target and Rating Average Price Target for Telix Pharmaceuticals$21.00 High Price Target$22.00 Low Price Target$20.00 Potential Upside/Downside+122.6%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (OTCMKTS:TLPPF) was last updated on 11/12/2026 by MarketBeat.com Staff. From Our PartnersWatch This NowJensen Huang, the man who launched the AI boom, just called what Elon Musk is chasing "the final frontier of A...StocksToTrade | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredTrump’s EO to send this $5 stock ripping higher…?President Trump's December executive order declared space a national security and economic priority, fueling a...Traders Agency | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredUranium Mine Flood That Sparked a 2006 Price Surge ReturnsIn 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...Digest Publishing | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telix Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Telix Pharmaceuticals With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
